| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8241995 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 9 Pages |
Abstract
Conclusion: Concurrent RCT with 5-FU/cisplatin has been associated with acceptable acute and long-term toxicity. Overall and cause-specific survival rates are encouraging. More than 80% of patients preserved their well-functioning bladder.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christian M.D., Dirk G. M.D., Frens S. M.D., Thomas M.D., Jürgen M.D., Rolf M.D., Claus M.D.,